STRS Ohio’s Anavex Life Sciences AVXL Stock Holding History

STRS Ohio’s Portfolio AVXL Stock Details AVXL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-7,700	Closed	-$68.5K	–	2184
2025 Q3	$68.5K	Hold	7,700	–	–	﹤0.01%	1934
2025 Q2	$71K	Buy	+7,700	New	+$65.7K	﹤0.01%	1956
2022 Q3	–	Sell	-4,300	Closed	-$43K	–	2008
2022 Q2	$43K	Sell	4,300 -5,200	-55%	-$49.3K	﹤0.01%	1875
2022 Q1	$116K	Hold	9,500	–	–	﹤0.01%	1817
2021 Q4	$164K	Hold	9,500	–	–	﹤0.01%	1784
2021 Q3	$170K	Sell	9,500 -4,700	-33%	-$93.6K	﹤0.01%	1814
2021 Q2	$324K	Sell	14,200 -2,000	-12%	-$29.6K	﹤0.01%	1694
2021 Q1	$242K	Buy	+16,200	New	+$177K	﹤0.01%	1766
2017 Q4	–	Sell	-9,600	Closed	-$39K	–	1879
2017 Q3	$39K	Hold	9,600	–	–	﹤0.01%	1822
2017 Q2	$51K	Hold	9,600	–	–	﹤0.01%	1784
2017 Q1	$55K	Buy	+9,600	New	+$49.6K	﹤0.01%	1761
2016 Q4	–	Sell	-10,500	Closed	-$38K	–	1918
2016 Q3	$38K	Sell	10,500 -400	-4%	-$1.68K	﹤0.01%	1797
2016 Q2	$66K	Buy	+10,900	New	+$52.7K	﹤0.01%	1732

Other funds holding AVXL

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

NWAM LLC Mercer Island, Washington $2B AUM 34.81% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Summit Financial Parsippany, New Jersey $9.12B AUM 27.44% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

STRS Ohio's AVXL Position: Q4 2025 in Review

STRS Ohio sold out of Anavex Life Sciences (AVXL) in Q4 2025, closing a stake of 7,700 shares — an estimated $68.5K sold.

STRS Ohio first reported a position in AVXL in Q2 2016 and held it in 13 quarters. The position peaked at $324K in Q2 2021. 184 funds tracked by Wall St. Rank hold AVXL as of Q4 2025.

STRS Ohio reported no remaining Anavex Life Sciences position as of Q4 2025 after selling out during the quarter.
STRS Ohio sold 7,700 Anavex Life Sciences shares in Q4 2025, an estimated $68.5K.
STRS Ohio first reported a position in Anavex Life Sciences in Q2 2016 and held it in 13 quarters.
STRS Ohio's Anavex Life Sciences position peaked at $324K in Q2 2021.
184 funds tracked by Wall St. Rank held Anavex Life Sciences as of Q4 2025.

Based on STRS Ohio's 13F filing for Q4 2025, filed 2 Feb 2026.